Enochian Biosciences CEO Mark Dybul's 2021 pay falls 66% to $430K
Enochian Biosciences reports 2021 executive compensation
By ExecPay News
Published: January 27, 2022
Enochian Biosciences reported fiscal year 2021 executive compensation information on January 27, 2022.
In 2021, two executives at Enochian Biosciences received on average a compensation package of $353K, a 54% decrease compared to previous year.
Average pay of disclosed executives at Enochian Biosciences
Mark Dybul, Chief Executive Officer, received $430K in total, which decreased by 66% compared to 2020. 100% of Dybul's compensation, or $430K, was in salary.
Luisa Puche, Chief Financial Officer, received a compensation package of $275K, which decreased by 2% compared to previous year. 100% of the compensation package, or $275K, was in salary.
Enochian Biosciences' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on January 27, 2022.